Trump announces reforms to accelerate access to psychedelic drug treatments - The Guardian
Quick Insights
The Bottom Line
President Trump announced reforms to speed up access to psychedelic drug treatments.
How This Affects You
These reforms could expand therapeutic options for Americans seeking mental health treatment using psychedelic drugs.
AI Summary
President Donald Trump announced reforms aimed at accelerating access to psychedelic drug treatments, as reported by The Guardian. This initiative focuses on streamlining regulatory processes to make these therapies more readily available to patients. The move signals a shift in the Trump administration's approach to mental health and substance abuse treatment, potentially broadening the scope of approved medical interventions. This could lead to increased research and development in psychedelic medicine, offering new options for conditions like PTSD and depression.
Source Coverage Map
13 of 43 tracked sources covered this story
Following this story?
Get notified when new coverage appears
Other Sources Covering This Story
5 sourcesMultiple outlets have reported on this story. Compare perspectives from different sources.
Trump speeds review of psychedelics after Joe Rogan texted him about ibogaine. 'Let's do it' - Fortune
Podcasters, Presidents, and Psychedelics: How Joe Rogan Got Trump Into Ibogaine
This article is part of a story we're tracking:
Trump Administration's Psychedelic Drug Research Initiative
President Trump has signed an executive order to accelerate research and review of psychedelic drugs for mental health disorders, including psilocybin and ibogaine. This initiative aims to expand access to these therapies, with podcaster Joe Rogan reportedly influencing the decision.
Trump Administration Accelerates Psychedelic Drug Research
President Donald Trump has signed an executive order to fast-track the review and research of psychedelic drugs for mental health disorders. This move aims to accelerate access to treatments like psilocybin and ibogaine, with the President publicly endorsing their potential.
Trump Administration's Psychedelic Drug Initiative
President Trump signed an executive order to accelerate access to psychedelic drug treatments and research for mental health. This initiative aims to expand the availability of substances like LSD, psilocybin, and ibogaine for medical use.
Trump Executive Order on Psychedelic Drug Research
President Trump signed an executive order to accelerate research and access to psychedelic drug treatments for mental health disorders. The initiative aims to fast-track the review process for substances like psilocybin and ibogaine.
US Political Figures and Psychedelic Drug Research
President Trump has signed an executive order to accelerate research and ease restrictions on psychedelic drug treatments for mental health disorders. This move has drawn attention from various political figures and media outlets, including podcaster Joe Rogan.
Trump Administration's Push for Psychedelic Drug Research
President Trump has signed an executive order to accelerate research and review processes for psychedelic-based therapies. This initiative, reportedly influenced by Joe Rogan, aims to loosen restrictions and explore the potential of psychedelics for mental health disorders.
Trump's Executive Order on Psychedelic Research
President Trump signed an executive order to ease restrictions and accelerate research into psychedelics, including ibogaine, LSD, and psilocybin, for mental health treatments. This move aims to expand access to these substances and expedite their review process.
Trump Administration's Psychedelic Drug Review
President Donald Trump has signed an executive order to accelerate the review and research of psychedelic-based therapies for mental health disorders. This move, reportedly influenced by figures like Joe Rogan, aims to fast-track access to treatments like ibogaine and psilocybin.
Trump's Psychedelics Research Initiative
President Trump signed an executive order to ease restrictions and accelerate research into psychedelics like ibogaine, LSD, and psilocybin for potential medical applications, particularly in mental health treatment. The initiative aims to expand access to these substances and expedite their review process.
Trump Administration's Psychedelics Initiative
President Trump has signed an executive order to accelerate research and review of psychedelic drugs for mental health disorders, reportedly influenced by a text from podcaster Joe Rogan. This initiative aims to fast-track therapies like psilocybin and ibogaine.
Government Spending & Oversight
Tracking how taxpayer dollars are spent, where oversight gaps exist, and what watchdogs are uncovering. From federal budget battles and earmark controversies to inspector general reports and GAO audits, this deep dive follows the money trail through every level of government. We examine defense spending, entitlement programs, infrastructure investments, and the growing national debt — focusing on accountability, waste, and the policies that shape how America allocates its resources.
Should this be getting more attention?
You Might Have Missed
Related stories from different sources and perspectives
PoliticsWhat to Know About Trump’s New Executive Order on Psychedelic Drugs
The order calls for the FDA to give expedited consideration to certain psychedelic drugs.
HealthTrump administration moves forward with certain drug reclassifications
President Trump signed an executive order on Saturday that paves the way for more research into psychedelics as treatment for certain mental illnesses. The signing follows Mr. Trump's move in December 2025 to reclassify marijuana as a less dangerous drug. Josh Kesselman, the founder of RAW rolling papers and publisher of High Times Magazine, joins with more.
PoliticsFACT FOCUS: Trump says drug trafficking by sea is down 98.2%. The numbers don't show that - AP News
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxPN0hCS3FkWU9qY3ZET3l2WjVnTTZhYXFxWnFWZ2dGMU0yYno3akxuRG9BMmdIdVltMVAyNXRrNVpkR2RhcFo4OVp6MzY2clFYV0JLRlpMSUNDN3lzMlgwWVdmR2VFemd3NXJSX3dsWU9Eam9BMHVFWjBOeF9EV3JkVE1aRUJzSFFtME1JZHlRSkVKYzJpZG5lY19MQ25pa01lbDBXTnpB?oc=5" target="_blank">FACT FOCUS: Trump says drug trafficking by sea is down 98.2%. The numbers don't show that</a> <font color="#6f6f6f">AP News</font>
HealthReport: Merck’s blockbuster cancer drug topped $200,000 a year under Trump
Despite the president’s plan to lower prescription medicine costs, the price of many of the most expensive drugs — including several immunotherapy treatments — have continued to rise.
PoliticsPresident Trump’s Landmark Order Advances Breakthrough Mental Health Treatments — Delivering New Hope to Veterans - The White House (.gov)
Health‘Uncharted territory’: uncertainty as US vaccine guidance falls apart under Trump
<p>Several shots – including flu and Covid – lost their CDC recommendations under overhauls from the White House</p><p>Several shots lost their recommendation from the US Centers for Disease Control and Prevention (CDC) after a judge’s stay against changes wrought by the Trump administration – which may affect access to the shots in some states. And no new vaccine recommendations may be made as long as the vaccines committee is halted.</p><p>Access to existing vaccines – and the future development of new vaccines – has been increasingly called into question under the second Trump administration, as the now-halted Advisory Committee on Immunization Practices (ACIP) made controversial recommendations and health officials made unilateral changes to routine vaccines, with long-term and global implications.</p> <a href="https://www.theguardian.com/us-news/2026/apr/15/uncertainty-vaccine-guidance-trump-administration">Continue reading...</a>
Trump labor secretary Lori Chavez-DeRemer resigns amid misconduct investigation - The Guardian
Did this story change how you see things?
Stories like this only matter when people see them. Help us get verified journalism in front of more eyes.
The Verity Ledger curates verified investigative journalism from trusted sources only.
See our sourcesMost Read This Week
Report: Merck’s blockbuster cancer drug topped $200,000 a year under Trump
4/14: The Takeout with Major Garrett
Trump’s Memphis Crime Task Force Arrested Over 800 Immigrants, Records Show. Only 2% of the Arrests Were for Violent Crimes.
Bipartisan duo that pushed Swalwell, Gonzales to resign says other lawmakers may be next
White House ramps up pressure to pass crypto bill as Congress returns
